Fungi

The deadliest organism you have probably never worried about might be a fungus. While bacteria and viruses get most of the attention, fungal infections kill over 1.5 million people every year, and that number is rising. Fungi are ancient, resilient, and biologically closer to humans than most people realize, which is exactly what makes them so difficult to treat. The same cellular machinery that keeps a fungal cell alive is often similar enough to our own that drugs designed to kill fungi can harm human cells too. That challenge sits at the heart of medical mycology.

Eukaryotic Complexity: Yeasts, Molds, and Mycology Fundamentals

Fungi are eukaryotes. Their cells have a true nucleus, membrane-bound organelles, and 80S ribosomes, just like human cells. This is a critical distinction from bacteria (which are prokaryotes with 70S ribosomes), because it means many of the antibiotic strategies that work beautifully against bacteria simply do not apply to fungi. You cannot target fungal ribosomes with the same drugs you use against bacterial ribosomes, because the fungal versions are too similar to our own.

Fungi come in three basic forms. Yeasts are single-celled fungi that reproduce by budding, where a smaller daughter cell pinches off from the parent. Candida albicans, the most common cause of yeast infections, is probably the best-known example. Molds are multicellular fungi that grow as long, branching filaments called hyphae. These hyphae weave together to form a visible mass called a mycelium, which is what you see when bread gets moldy. Then there are dimorphic fungi, which can switch between yeast and mold forms depending on the temperature. At body temperature (37°C), they grow as yeast; at room temperature (25°C), they grow as mold. This shape-shifting ability is directly connected to their ability to cause disease in humans.

The fungal cell wall is made of chitin (not the peptidoglycan found in bacteria), and the fungal cell membrane contains ergosterol instead of the cholesterol found in human cell membranes. That difference in membrane composition is one of the few molecular targets that antifungal drugs can exploit without causing too much collateral damage to the patient. Most antifungal medications, including the azoles (fluconazole, itraconazole) and the polyenes (amphotericin B), work by disrupting ergosterol synthesis or binding directly to ergosterol in the fungal membrane.

Mechanisms of Growth: Budding, Hyphal Elongation, and Spore Dispersal

Fungal infections range from mildly annoying to life-threatening, and the severity depends on where the infection occurs and how compromised the patient's immune system is. Superficial mycoses affect the outermost layers of skin and hair. Cutaneous mycoses, like ringworm and athlete's foot, penetrate slightly deeper into the skin, nails, and hair follicles. Subcutaneous mycoses enter through wounds and can cause chronic infections in the tissue beneath the skin. Systemic mycoses are the most dangerous, spreading through the bloodstream to affect internal organs, and they are a major killer in immunocompromised patients, including those with HIV/AIDS, organ transplant recipients on immunosuppressive drugs, and cancer patients undergoing chemotherapy.

Candida albicans is the most clinically significant yeast. It lives harmlessly in the mouth, gut, and vaginal tract of most healthy people, kept in check by the rest of the microbiome and the immune system. When that balance is disrupted (by antibiotics wiping out competing bacteria, for example, or by immune suppression), Candida can overgrow and cause infections ranging from oral thrush to invasive bloodstream infections. Candida auris, a more recently identified species, is listed by the CDC as an urgent antimicrobial resistance threat because it is frequently resistant to multiple antifungal drugs and can spread rapidly in healthcare settings. Aspergillus is a mold that produces airborne spores which healthy people inhale and clear without issue, but which can cause severe invasive pulmonary aspergillosis in immunocompromised patients.

In the lab, fungi are identified using a combination of techniques. Sabouraud dextrose agar is a selective growth medium that favors fungi over bacteria. A KOH (potassium hydroxide) mount dissolves human tissue in a clinical sample, leaving fungal elements visible under the microscope. More advanced identification uses molecular methods and MALDI-TOF mass spectrometry.

Clinical Pathology: Opportunistic Infections and Antifungal Targets

Developing new antifungal drugs is one of the biggest challenges in infectious disease medicine. Because fungi are eukaryotes like us, there are very few molecular targets that drugs can hit without also harming human cells. The current antifungal arsenal is small compared to the antibiotic arsenal, and resistance is growing. Candida auris has already shown resistance to all three major classes of antifungal drugs in some cases, leaving clinicians with very few options.

Climate change is also expanding the geographic range of certain pathogenic fungi. Species that were once confined to tropical regions are now appearing in temperate climates. The combination of a growing immunocompromised population (due to aging, cancer treatment, and organ transplantation), limited drug options, and expanding fungal habitats makes mycology one of the most urgent areas of research in microbiology today.

Case Study: Managing Invasive Aspergillosis in an Immunocompromised Patient

A patient with leukemia is admitted for chemotherapy. Two weeks into treatment, their immune cell counts drop severely. They develop a persistent fever that does not respond to antibiotics. A CT scan of the lungs shows a characteristic "halo sign," and a blood test for galactomannan (a fungal cell wall component) comes back positive. The diagnosis is invasive pulmonary aspergillosis. Treatment starts immediately with voriconazole, but the outcome depends heavily on how quickly the patient's immune system can recover. This scenario plays out in hospitals around the world every day, and understanding fungal biology is what makes rapid diagnosis and treatment possible.

Essential Fungal Terminology